Akut mieloid leukémia (AML): vizsgálatok itt: Görögország
8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1. fázisCsak meghívásosA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Athens
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 3. fázisTaking peopleA Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Where
- Alexandroupoli, Athens, Chaïdári, Ioannina, Rio, Thessaloniki
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06852222 · EU 2024-520154-38-00 - 3. fázisTaking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Chaïdári, Larissa, Patras
- Életkor
- 12 év and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - No phaseTaking peopleEarly Detection and Screening of Hematological Malignancies - SANGUINE
- Where
- Athens
- Életkor
- 18 év and over
- People
- 3000 worldwide
- Run by
- JaxBio Ltd
See details and how to joinNCT05735704 - 3. fázisTaking peopleStudies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Where
- Alexandroupoli, Athens, Chaïdári, Ioannina, Thessaloniki
- Életkor
- 18 év and over
- People
- 1300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT07007312 · EU 2025-521314-25-00 - 2. fázisTaking peopleAdministration of Gilteritinib to eliminate MRD in patients with AML and FLT3-ITD mutation.
- Where
- Athens, Chaïdári, Thessaloniki
- Életkor
- 18 év and over
- People
- 58
- Run by
- Hellenic Society Of Hematology
See details and how to join2025-521875-30-00 · EU 2025-521875-30-00 - 3. fázisTaking peopleAn Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
- Where
- Athens
- Életkor
- 18 év and over
- People
- 245 worldwide
- Run by
- Servier Affaires Médicales
See details and how to joinNCT05907057 · EU 2022-501709-11-00 - 1/2. fázisTaking peopleAB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Where
- athens, Athens, Patra
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- AB Science
See details and how to joinNCT05211570 · EU 2024-516641-39-00